Gg. Nomikos et al., THE PUTATIVE ATYPICAL ANTIPSYCHOTIC DRUG AMPEROZIDE PREFERENTIALLY INCREASES C-FOS EXPRESSION IN RAT MEDIAL PREFRONTAL CORTEX AND LATERAL SEPTUM, Neuropsychopharmacology, 17(3), 1997, pp. 197-201
The effects of acute, systemic administration of the putative atypical
antipsychotic drug amperozide on c-fos expression in the rat forebrai
n were studied by means of Fos immunohistochemistry. Amperozide signif
icantly increased the number of Fos-immunoreactive nuclei in the media
l prefrontal cortex and the lateral septum but not in the nucleus accu
mbens (shell or core), the striatum, or the amygdala. With the excepti
on of the nucleus accumbens-shell, where amperozide failed to produce
statistically immunoreactivity following amperozide was similar to tha
t induced by atypical, but not by typical, antipsychotic drugs. In add
ition, after amperozide the number of Fos-positive nuclei was higher i
n the nucleus accumbens than in the dorsolateral striatum, a character
istic that is common to all known atypical antipsychotic agents. (C) 1
997 American College of Neuropsychopharmacology. Published by Elsevier
Science Inc.